Subsidy Information and Financing Scheme SDLCarbamazepine Controlled-Release Tablet 200 mg, 400 mg SDLCarbamazepine Syrup 100 mg/5 mL SDLCarbamazepine Tablet 200 mg
Post Marketing Information DHCPL 28/08/2013 Change in shelf-life, storage conditions and manufacturing site for Tegretol 200 Tablet 200mg (SIN00352P) DHCPL 30/04/2013 Recommendations for HLA-B*1502 genotype testing prior to initiation of carbamazepine in new patients
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Controlled-Release Tablet 200 mg Alexandra Hospital Changi General Hospital Institute of Mental Health KK Women's and Children's Hospital Khoo Teck Puat Hospital National Cancer Centre National Healthcare Group Polyclinics Ng Teng Fong General Hospital National University Hospital National University Polyclinics Sengkang General Hospital Singapore General Hospital SingHealth Polyclinics Tan Tock Seng Hospital Woodlands Health Campus Controlled-Release Tablet 400 mg National Cancer Centre Sengkang General Hospital Singapore General Hospital Syrup 100 mg/5 mL KK Women's and Children's Hospital Ng Teng Fong General Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital Tablet 200 mg Alexandra Hospital Changi General Hospital Institute of Mental Health Khoo Teck Puat Hospital National Cancer Centre National Healthcare Group Polyclinics Ng Teng Fong General Hospital National University Hospital National University Polyclinics Sengkang General Hospital Singapore General Hospital SingHealth Polyclinics Tan Tock Seng Hospital Woodlands Health Campus
ORAL Select a brand starting with the letter: A S T APO-CARBAMAZEPINE TABLET 200 MG [SIN05735P] STORILAT 200 TABLET 200 MG [SIN05583P] TEGRETOL 200 TABLET 200 MG [SIN00352P] TEGRETOL CR 200 TABLET 200 MG [SIN02387P] TEGRETOL CR 400 TABLET 400 MG [SIN02388P] See all TEGRETOL ORAL SUSPENSION 2% [SIN00510P]